Although solid dosage forms like tablets and capsules continue to dominate the global pharmaceutical market, many people find them challenging to take. There is evidence to suggest that oral liquid dosage forms may offer untapped opportunities, with the potential to: improve patient experiences and compliance reduce healthcare costs create new revenue streams. In a study[…]
Don’t Ignore the Market Opportunities of Oral Liquid Dosage Forms
blog, Case Study, LGM Pharma Tags: dosage formLGM Pharmaliquid doseoral Apr 04, 2021
LGM Helps Pharma Manage Supply Chain Risks with Added Services Through Nexgen Acquisition
blog, Bulk Active Ingredient, Drug Research & Development API, LGM Pharma, Supply Chain Tags: analytical methods developmentCDMODrug Developmentdrug manufacturingformulations developmentLGM PharmaNexgenpackagingsemi-solidsolid dosesupply chain Nov 02, 2020
COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of many other, more localized supply issues in the last decade, it has brought about a near-global assessment that supply chains need to be more tightly controlled and redundant – and less dependent on external, at-risk suppliers. In a sense,[…]
How to Stay Compliant in a Changing Pharma Regulatory Landscape
Compounding API Tags: APIblogcomplianceLGM Pharmaqualityregulatory Dec 06, 2019
In 2012, contaminated medications from the New England Compounding Center (NECC) caused a meningitis outbreak, leading to tragedy when 64 patients were killed and 751 injured. Unsurprisingly, the pharmacy compounding industry has been under close scrutiny ever since. The FDA has now become the primary agency for regulating compounding pharmacies such as NECC. Historically, compounding[…]
